B. Riley Securities Reiterates Buy on LifeMD, Maintains $12 Price Target
Portfolio Pulse from Benzinga Newsdesk
B. Riley Securities analyst William Woods has reiterated a Buy rating on LifeMD (NASDAQ:LFMD) and maintained a $12 price target.
May 21, 2024 | 3:45 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
B. Riley Securities analyst William Woods has reiterated a Buy rating on LifeMD and maintained a $12 price target.
The reiteration of a Buy rating and the maintenance of a $12 price target by a reputable analyst can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100